Skip to main content

Loading market data...

BLCO

Bausch + Lomb Corporation

NYSE • United states

$16.97

+$0.36

(+2.17%)

Source: Yahoo Finance · Quote time Oct 20, 2026 17:49 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

Bausch + Lomb Corporation (BLCO)

Unavailable

Quotes may be delayed

$6.06B

Market Cap

169,555

Volume

Unavailable

P/E Ratio

Unavailable

Div Yield

Bausch + Lomb Corporation Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 520 APPLEWOOD CRESCENT, VAUGHAN, A6
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

13 Oct 2026

Bausch + Lomb Corporation reported A director or senior management change or compensation event

Bausch + Lomb Corporation filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

6 Aug 2026

Bausch + Lomb Corporation reported A material agreement

Bausch + Lomb Corporation filed an 8-K covering a material agreement, a director or senior management change or compensation event, another company event, supporting financial statements or exhibits.

30 Jul 2026

Bausch + Lomb Corporation filed Form 10-Q

Bausch + Lomb Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

29 Jul 2026

Bausch + Lomb Corporation reported Operating or financial results

Bausch + Lomb Corporation filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

21 May 2026

Bausch + Lomb Corporation reported Shareholder voting results

Bausch + Lomb Corporation filed an 8-K covering shareholder voting results.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$367.00M

Total assets (USD)$13.86B

Total liabilities (USD)$7.42B

Shareholders' equity (USD)$6.38B

Long-term debt (USD)$5.05B

Debt due within a year (USD)$28.00M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$1.39B	$83.00M	−$14.00M	−$0.04	10-Q · 29 Jul 2026
Q1 2026	$1.24B	$33.00M	−$71.00M	−$0.20	10-Q · 29 Apr 2026
Q4 2025	$1.41B	$112.00M	−$58.00M	Unavailable	10-K · 18 Feb 2026
Q3 2025	$1.28B	$95.00M	−$28.00M	−$0.08	10-Q · 29 Oct 2025
Q2 2025	$1.28B	−$11.00M	−$62.00M	−$0.18	10-Q · 30 Jul 2025
Q1 2025	$1.14B	−$83.00M	−$212.00M	−$0.60	10-Q · 30 Apr 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $20.56

21.2% upside potential

📈

Strong Buy

Unavailable

👍

Buy

6

⏸️

Hold

4

📉

Sell

1

11 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 20 Oct 2026, 17:51 UTC Targets range 16.00–24.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

12

Aug 2026

Trebbi Barbara

Director

Grant or award

Unavailable per share

11,776 shares

12

Aug 2026

PAUL LAURENCE E

Director

Grant or award

Unavailable per share

11,776 shares

12

Aug 2026

Chersi Robert J

Director

Grant or award

Unavailable per share

11,776 shares

10

Aug 2026

Munsch Frederick

SVP, Controller and CAO

Open-market sale

$16.78 per share

52,900 shares

7

Aug 2026

VON ESCHENBACH ANDREW C.

Director

Open-market sale

$16.58 per share

6,059 shares

6

Aug 2026

VON ESCHENBACH ANDREW C.

Director

Open-market sale

$16.50 per share

12,500 shares

5

Aug 2026

Stewart Andrew J.

President, GPIC

Grant or award

Unavailable per share

16,778 shares

5

Aug 2026

Munsch Frederick

SVP, Controller and CAO

Grant or award

Unavailable per share

9,091 shares

5

Aug 2026

Hashad Yehia

EVP of R&D and CMO

Grant or award

Unavailable per share

20,973 shares

Top Shareholders

Icahn Carl C

3,500,000 shares

0% change

6/30/2026

Oaktree Capital Management Lp

3,441,042 shares

1.724% change

6/30/2026

Deutsche Bank Ag\

3,423,046 shares

-2.987% change

6/30/2026

D. E. Shaw & Co., Inc.

3,323,021 shares

5.454% change

6/30/2026

Davidson Kempner Capital Management Lp

3,158,972 shares

43.644% change

6/30/2026

Goldentree Asset Management Lp

2,660,508 shares

0% change

6/30/2026

Price T Rowe Associates Inc /Md/

2,161,232 shares

76.484% change

6/30/2026

Caspian Capital Lp

1,999,043 shares

0% change

6/30/2026

Glenview Capital Management, Llc

1,918,148 shares

0.401% change

6/30/2026

Arrowstreet Capital, Limited Partnership

1,364,980 shares

38.991% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 20 Oct 2026, 17:51 UTC· 1 day ago

Research coverage and investment tools

Bausch + Lomb Corporation (BLCO) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Ophthalmic Goods). Its last price was US$16.97 on 20 Oct 2026. That is 57% of the way from its 52-week low of US$14.44 to its 52-week high of US$18.92. Its market capitalisation was US$6.06 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$1.39B	$83.00M	−$14.00M	−$0.04	—	6.0%	$82.00M	10-Q · 29 Jul 2026 (opens in a new tab)
Q1 2026	$1.24B	$33.00M	−$71.00M	−$0.20	—	2.7%	−$68.00M	10-Q · 29 Apr 2026 (opens in a new tab)
Q4 2025	$1.41B	$112.00M	−$58.00M	Unavailable	—	8.0%	$60.00M	10-K · 18 Feb 2026 (opens in a new tab)
Q3 2025	$1.28B	$95.00M	−$28.00M	−$0.08	—	7.4%	$63.00M	10-Q · 29 Oct 2025 (opens in a new tab)
Q2 2025	$1.28B	−$11.00M	−$62.00M	−$0.18	—	-0.9%	−$54.00M	10-Q · 30 Jul 2025 (opens in a new tab)
Q1 2025	$1.14B	−$83.00M	−$212.00M	−$0.60	—	-7.3%	−$135.00M	10-Q · 30 Apr 2025 (opens in a new tab)

Cash and equivalents: $367.00M
Total assets: $13.86B
Total liabilities: $7.42B
Shareholders' equity: $6.38B
Long-term debt: $5.05B
Debt due within a year: $28.00M

8-K · 13 Oct 2026 · Management change

Bausch + Lomb Corporation reported A director or senior management change or compensation event (opens in a new tab)

Bausch + Lomb Corporation filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 6 Aug 2026 · Management change

Bausch + Lomb Corporation reported A material agreement (opens in a new tab)

Bausch + Lomb Corporation filed an 8-K covering a material agreement, a director or senior management change or compensation event, another company event, supporting financial statements or exhibits.
10-Q · 30 Jul 2026

Bausch + Lomb Corporation filed Form 10-Q (opens in a new tab)

Bausch + Lomb Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 29 Jul 2026

Bausch + Lomb Corporation reported Operating or financial results (opens in a new tab)

Bausch + Lomb Corporation filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
8-K · 21 May 2026

Bausch + Lomb Corporation reported Shareholder voting results (opens in a new tab)

Bausch + Lomb Corporation filed an 8-K covering shareholder voting results.

Insider	Date	Transaction	Shares	Average price	Filing
Trebbi Barbara Director	12 Aug 2026	Grant or award (A)	+11,776	—	Form 4 (opens in a new tab)
PAUL LAURENCE E Director	12 Aug 2026	Grant or award (A)	+11,776	—	Form 4 (opens in a new tab)
Chersi Robert J Director	12 Aug 2026	Grant or award (A)	+11,776	—	Form 4 (opens in a new tab)
Munsch Frederick SVP, Controller and CAO	10 Aug 2026	Open-market sale (S)	−52,900	$16.78	Form 4 (opens in a new tab)
VON ESCHENBACH ANDREW C. Director	7 Aug 2026	Open-market sale (S)	−6,059	$16.58	Form 4 (opens in a new tab)
VON ESCHENBACH ANDREW C. Director	6 Aug 2026	Open-market sale (S)	−12,500	$16.50	Form 4 (opens in a new tab)
Stewart Andrew J. President, GPIC	5 Aug 2026	Grant or award (A)	+16,778	—	Form 4 (opens in a new tab)
Munsch Frederick SVP, Controller and CAO	5 Aug 2026	Grant or award (A)	+9,091	—	Form 4 (opens in a new tab)
Hashad Yehia EVP of R&D and CMO	5 Aug 2026	Grant or award (A)	+20,973	—	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Icahn Carl C	6/30/2026	3,500,000	0%
Oaktree Capital Management Lp	6/30/2026	3,441,042	1.724%
Deutsche Bank Ag\	6/30/2026	3,423,046	-2.987%
D. E. Shaw & Co., Inc.	6/30/2026	3,323,021	5.454%
Davidson Kempner Capital Management Lp	6/30/2026	3,158,972	43.644%
Goldentree Asset Management Lp	6/30/2026	2,660,508	0%
Price T Rowe Associates Inc /Md/	6/30/2026	2,161,232	76.484%
Caspian Capital Lp	6/30/2026	1,999,043	0%
Glenview Capital Management, Llc	6/30/2026	1,918,148	0.401%
Arrowstreet Capital, Limited Partnership	6/30/2026	1,364,980	38.991%

Previous close: 16.61 USD
Day range: 16.67 – 17.05 USD
52-week range: 14.44 – 18.92 USD
Volume: 169,555
Market cap: $6.06B
EPS (FY 2025, diluted): −1.02 USD
Shares outstanding: 357.17M
Beta (5Y monthly): 0.50

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 17:49 UTC· 1 day ago

Average volume, P/E and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:38 UTC· 35 minutes ago

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding.

This research is not available for BLCO yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.